StockStory.org on MSN
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics stocks trade down, what you need to know
What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients.
Zacks Investment Research on MSN
3 promising genomics stocks to add to your portfolio in 2026
An updated edition of the June 2, 2026, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this area ...
Why 10x Genomics stock is back in focus after earnings and index changes 10x Genomics (TXG) has been drawing fresh attention after quarterly results topped analyst revenue and EPS forecasts, even as ...
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know why the ILMN shares look promising.
Genomics is the study of genes and how they operate. Numerous quickly expanding businesses are arising in the genomics industry as a result of technological advancements that significantly reduce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results